New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics
Maria Lobo, Thomas Whitehurst, Stephen J. Kaar, Oliver Howes
Topics & Concepts
TolerabilityPartial agonistPharmacologyDopamineDopamine receptor D2MedicineDopamine receptor D3Schizophrenia (object-oriented programming)Clinical trialPsychologyAntagonistInternal medicinePsychiatryAdverse effectReceptorSchizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorBipolar Disorder and Treatment